CIK 0000025743 · Non-accelerated filer<br>Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 870233535
- Phone
- 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-18 | Thompson Tommy G Director | Option exercise · Restricted Stock Units | −2,976 | 0 | ||
| 2022-08-18 | BISARO PAUL Director | Option exercise | +1,984 | 5,922 | ||
| 2022-08-18 | BISARO PAUL Director | Option exercise · Restricted Stock Units | −1,984 | 0 | ||
| 2022-07-29 | Rubric Capital Management LP 10% owner | Purchase | +565,000 | $4.72 | $2.7M | 1,721,953 |
| 2022-07-29 | Rubric Capital Management LP 10% owner | Purchase | +15,000 | $822.21 | $12.3M | 15,000 |
| 2022-07-18 | Rubric Capital Management LP 10% owner | Purchase | +17,688 | $6.03 | $107K | 1,156,953 |
| 2022-07-15 | Rubric Capital Management LP 10% owner | Purchase | +64,892 | $5.56 | $361K | 1,139,265 |
| 2022-03-31 | Walker Marlan D General Counsel | Grant or award · Performance Stock Units | +260,000 | 260,000 | ||
| 2022-03-31 | O'Dowd Hugh Chief Executive Officer | Grant or award · Performance Stock Units | +2,125,000 | 2,125,000 | ||
| 2022-03-31 | Glickman Mark A Chief Business Officer | Grant or award · Performance Stock Units | +260,000 | 260,000 | ||
| 2022-03-31 | Donegan Michael C CAO and VP of Finance | Grant or award · Performance Stock Units | +120,000 | 120,000 | ||
| 2022-03-23 | Glickman Mark A Chief Business Officer | Grant or award · Restricted Stock Units | +260,000 | 260,000 | ||
| 2022-03-23 | O'Dowd Hugh Chief Executive Officer | Grant or award · Restricted Stock Units | +2,125,000 | 2,125,000 | ||
| 2022-03-23 | Walker Marlan D General Counsel | Grant or award · Restricted Stock Units | +260,000 | 260,000 | ||
| 2022-03-23 | Donegan Michael C CAO and VP of Finance | Grant or award · Restricted Stock Units | +120,000 | 120,000 | ||
| 2022-03-23 | Walker Marlan D General Counsel | Grant or award · Restricted Stock Units | +260,000 | 260,000 | ||
| 2022-03-14 | Walker Marlan D General Counsel | Option exercise | +230,000 | 258,908 | ||
| 2022-03-14 | Walker Marlan D General Counsel | Option exercise · Restricted Stock Units | −230,000 | 0 | ||
| 2021-11-30 | Donegan Michael C CAO and VP of Finance | Option exercise | +115,000 | 129,158 | ||
| 2021-11-30 | Donegan Michael C CAO and VP of Finance | Sale | −29,790 | $0.54 | $16K | 99,368 |
Page 7 of 11 · 206 trades